UC

Udal Chandan Lilhare

Active Director Designated Partner DIN 11802519
DIN 11802519 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Udal Chandan Lilhare

Udal Chandan Lilhare is a Designated Partner at Blessbio Pharma Llp (since 2026).

DIN 11802519
Primary Designation Designated Partner
First Appointment 02 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Jul 20262026Active

Board colleagues of Udal Chandan Lilhare

NameDINCompanyDesignation
Sanjay Khatuji Kamdi11802520Blessbio Pharma LlpDesignated Partner
Sanjiv Pandurang Chandankhede11724338Blessbio Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Blessbio Pharma Llp
Premium access

Shareholding and investment profile for Udal Chandan Lilhare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Udal Chandan Lilhare

Udal Chandan Lilhare currently holds 1 directorship: Blessbio Pharma Llp (Designated Partner, since 02 Jul 2026).

Udal Chandan Lilhare was first appointed on 02 Jul 2026 as Designated Partner at Blessbio Pharma Llp.

The current boards of Udal Chandan Lilhare's companies include Sanjay Khatuji Kamdi (Blessbio Pharma Llp), Sanjiv Pandurang Chandankhede (Blessbio Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available